Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Current Deferred Revenue (2019 - 2025)

Legend Biotech filings provide 7 years of Current Deferred Revenue readings, the most recent being $11.3 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 75.91% to $11.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.3 million, a 75.91% decrease, with the full-year FY2025 number at $11.3 million, down 75.91% from a year prior.
  • Current Deferred Revenue hit $11.3 million in Q4 2025 for Legend Biotech, down from $22.6 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $237.2 million in Q3 2021 to a low of -$245.8 million in Q1 2022.
  • Median Current Deferred Revenue over the past 5 years was $36.4 million (2025), compared with a mean of $24.2 million.
  • Biggest five-year swings in Current Deferred Revenue: soared 96471.42% in 2021 and later plummeted 95145.35% in 2022.
  • Legend Biotech's Current Deferred Revenue stood at -$60.6 million in 2021, then crashed by 305.4% to -$245.8 million in 2022, then skyrocketed by 121.56% to $53.0 million in 2023, then fell by 11.53% to $46.9 million in 2024, then plummeted by 75.91% to $11.3 million in 2025.
  • The last three reported values for Current Deferred Revenue were $11.3 million (Q4 2025), $22.6 million (Q3 2025), and $33.2 million (Q2 2025) per Business Quant data.